GS
Gnanatilakan Sebastian
About Gnanatilakan Sebastian
Data last updated:
Gnanatilakan Sebastian is a Director at Novel Drugs Limited (since 1996). The companies operate in Pharma. Earlier, Gnanatilakan Sebastian was a Director at Medi Green Field Health Care Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novel Drugs Limited U24231TN1994PLC027710 | Director | 30 Jul 1996 | 1994 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Medi Green Field Health Care Private Limited U33100TN2009PTC070397 | Director | 06 Jan 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Gnanatilakan Sebastian
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandra Gnanatilakan | 02326320 | Novel Drugs Limited | Director |
| Karunakaran Sebastin | 02335775 | Novel Drugs Limited | Director |
| Mary Vasundra Justine | 02337224 | Novel Drugs Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gnanatilakan Sebastian
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gnanatilakan Sebastian
Gnanatilakan Sebastian currently holds 1 directorship: Novel Drugs Limited (Director, since 30 Jul 1996).
Gnanatilakan Sebastian was first appointed on 30 Jul 1996 as Director at Novel Drugs Limited. The most recent appointment on record is 06 Jan 2009 at Medi Green Field Health Care Private Limited.
Gnanatilakan Sebastian held 1 earlier board appointment: Medi Green Field Health Care Private Limited (Director, from 06 Jan 2009).
The current boards of Gnanatilakan Sebastian's companies include Chandra Gnanatilakan (Novel Drugs Limited), Karunakaran Sebastin (Novel Drugs Limited), Mary Vasundra Justine (Novel Drugs Limited).